Home
>
US Stocks
>
Mannkind Corp
Mannkind Corp
MNKD

Mannkind Corp (MNKD)

$4.640.22%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
4.5
Today Low/High
4.4 / 4.66
52 Week Low/High
$1.56 / $6.25
P/E ratio
-12.0329
Market Cap
$1.04B

Company Details

MannKind Corporation focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, its first FDA-approved product and the only inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut.
Organisation
Mannkind Corp
Headquaters
Westlake Village, California, United States
Employees
241
Industry
Health Technology
CEO
Michael Castagna

Discover more

Frequently Asked Questions

What is Mannkind Corp (MNKD) share price today?

Can Indians buy Mannkind Corp (MNKD) shares?

How can I buy Mannkind Corp (MNKD) shares from India?

Can Fractional shares of Mannkind Corp (MNKD) be purchased?

What are the documents required to start investing in Mannkind Corp (MNKD) stocks?

We are a SEBI registered investement advisor